The use of opioids in late-stage COPD—Where are we now?
Dec 04, 2024

At present, data from a meta-analysis and two large, randomized, controlled studies indicate that in people with severe chronic breathlessness secondary to COPD, a short trial of low dose, sustained release morphine is safe and potentially beneficial. 


Lung Sask in collaboration with RESPTREC® offers the Professional Education Portal as a method for respiratory educators and health care providers to enhance their professional learning with continuing education opportunities.

Over 5000+ more articles available in the Professional Education Portal.

Read articles and watch video presentations on the most recent research, position papers and guidelines. Track your CE time with the provided logbook.

Access this free resource